Researchers
Discover all researchers in life sciences
Loading researchers...
Discover all researchers in life sciences
Researcher at Biotechnology
Ask questions about Prosper Obed Chukwuemeka's research, publications, and ongoing work
Conducted molecular docking studies to identify potential inhibitors of SARS-CoV-2 non-structural proteins using gallic acid derivatives, contributing to the search for COVID-19 therapeutics.
Utilized computer-assisted therapeutic discovery approaches to identify novel inhibitors of HSP27, a promising target for cancer therapy.
Developed a predictive hybrid paradigm to identify 1,3,4-thiadiazole derivatives as CDK6 inhibitors against MCF-7 breast cancer cells, offering insights into novel cancer therapeutics.
Investigated small molecule inhibitors targeting p53-MDM2 interactions for cancer therapy, providing a computational perspective on therapeutic strategies.
Designed a vaccine-based therapy against Epstein-Barr virus-associated tumors using an immunoinformatics approach, contributing to the development of novel cancer treatments.
Identified a 1,8-naphthyridine-containing compound that inhibits p53-MDM2/X interaction signaling, offering a computational perspective on cancer therapy.
Applied fragment-based drug design, 2D-QSAR, and DFT calculations to identify potential inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.
Dr. Prosper Obed Chukwuemeka is a biotechnology researcher specializing in computational drug discovery and cancer therapeutics. His work focuses on identifying novel drug candidates and understanding molecular mechanisms through in silico approaches, contributing significantly to the field of pharmaceuticals.
Researchers with overlapping expertise and complementary work
Finding similar researchers...